Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Ophthalmology

 

Outpatient models post-Covid

Join us to hear from our expert panel address and to share your own experiences. You will be seeing · Richard Banks, Chief Strategy Officer, Virtus Health · Martin Bundschu, Director, Smile Eyes · Tomas Aubell, MD Cosmea Pflege Holding, former CEO Colosseum Dental and ex Jacobs Chief Investment Officer · Ben Faircloth, global co-head of L.E.K. Consulting’s healthcare […]

Bergman set to enter German ophthalmology market

HBI hears that Dutch and Nordic ambulatory and ophthalmology clinic chain Bergman Clinic is looking to acquire two substantial outpatient ophthalmology chains in Germany. This would mark its entry into the country’s ophthalmology market – and a significant one at that. We talk to a source about the targets, the price, and what this means for the wider market. Longer-term Bergman itself is likely to sell.

COVID-19 and Emerging Market healthcare

We talk to two of the world's largest investors in emerging market health care about Covid's likely impact. Despite so far much lower death rates, the initial effect on health care operators has been worse than in Europe. Covid is set to destroy several motors for growth such as healthcare tourism and the deployment of […]

Covid: The double whammy – who will be left standing?

In a recent paper on the medtech outlook for Europe, UBS, looked at how Singapore and Toronto bounced back from pandemics. Pent up demand simply led to double growth rates the year after. But Covid is two things: a pandemic coupled to a steep recession, almost certainly worse than 2008. We look at what this means for a sector where private equity has often geared up to the hilt.

Booking data shows outpatient has all but stopped

Patient footfall for outpatient care across the world has all but stopped. Exclusive data from DocPlanner shows which specialities have seen the biggest drop in appointments booked and where telemedicine is really picking up some of the slack. We assess this against outpatient volumes in Singapore during SARS to see when it might pick up.

Exclusive prediction: Pandemic reaching turning point in Europe?

An exclusive analysis by Chinese insurance giant Ping An suggests COVID-19 cases could reach a turning point in the next few days, hitting the peak of new confirmed cases by later this week / early April,  with that figure set to fall thereafter.

Will Bergman buy big before prospective sale?

Rumours persist that Bergman Clinic, the Dutch and Nordic ambulatory and ophthalmology clinic chain, is looking to sell and may have one large acquisition in its sights ahead of any process starting. HBI speaks briefly to two banking sources, and a Netherlands-based advisor to find out more.

Nordic Capital ‘buying SpaMedica’

European-focused PE firm Nordic Capital is reportedly buying SpaMedica, the UK's largest cataract surgery provider, in a deal that values the ophthalmic group at around £300m.

COVID-19: Threats and opportunities

Covid-19 is going to have a huge impact on for-profit healthcare services. In the first of a two-part report, we look at what that will be at a sector and country level. Digital health looks like being a winner, Ping An claims online consultations are up tenfold, with the spectre of a crash in elective procedures hanging over for-profit hospitals and specialist outpatient chains. We also look at the likely impact on M&A.  The second part of this report, focussing on the care sector, will be published next week.

Investors for Health opens door to all serious emerging market investors

All emerging market health-care investors are welcome to join Investors for Health (I4H), a newish community of 30+ investors including development banks, private equity, venture capital and impact funds. The group aims to jointly focus on private healthcare development in emerging markets with a focus on equity and alignment with universal healthcare cover. It next meets at HBI 2020, April 20-22, London. Its formation reflects a quiet revolution in the role of for-profit healthcare and its importance in bridging the World Health Organisation's estimated $686bn funding gap in low-and-middle-income countries to achieve the United Nation’s Sustainable Development Goal #3 (“Ensure healthy lives and promote well-being for all at all ages”).

Find Us